• PDF / 169,151 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 58 Downloads / 135 Views

DOWNLOAD

REPORT

---

1 S

Fatigue: case report In a study involving 33 cancer patients, one patient [age and sex not stated] was described, who developed fatigue during treatment with cisplatin and paclitaxel. The patient, who was diagnosed with cancer, received unspecified neoadjuvant chemotherapy and underwent interval debulking surgery. The patient then started receiving chemotherapy with cisplatin and paclitaxel [routes and doses not stated] for 6 cycles. However, the patient developed grade 3–4 fatigue secondary to paclitaxel and cisplatin [duration of treatment to reaction onset and outcome not stated]. Rios-Doria E, et al. Toxicity and survival associated with IV/IP chemotherapy following neoadjuvant chemotherapy and interval debulking surgery for epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology 159 (Suppl. 1): 127-128 (plus poster) abstr. 269, Oct 2020. Available from: URL: http://doi.org/10.1016/ 803514404 j.ygyno.2020.05.157 [abstract]

0114-9954/20/1830-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 14 Nov 2020 No. 1830